-
Loading metrics
Open Access
Peer-reviewed
Research Article
Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection
-
Bryce M. Warner,
Roles Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
⨯ -
Robert Vendramelli,
Roles Data curation, Investigation, Methodology
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
⨯ -
Amrit S. Boese,
Roles Data curation, Formal analysis, Writing – review & editing
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
⨯ -
Jonathan Audet,
Roles Data curation, Formal analysis, Methodology, Writing – review & editing
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
⨯ -
Nikesh Tailor,
Roles Investigation, Methodology, Writing – review & editing
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
⨯ -
Courtney Meilleur,
Roles Investigation, Methodology, Writing – review & editing
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
⨯ -
Nathan Glowach,
Roles Formal analysis, Investigation, Methodology, Writing – review & editing
Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada
⨯ -
Marnie Willman,
Roles Investigation, Methodology, Writing – review & editing
Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada
⨯ -
Thang Truong,
Roles Investigation, Methodology
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
⨯ -
Estella Moffat,
Roles Investigation, Methodology
Affiliation National Centre for Foreign Animal Diseases, Canadian Food Inspection Agency, Winnipeg, Manitoba, Canada
⨯ -
Kevin Tierney,
Roles Investigation, Methodology, Resources
Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
⨯ - Beata Kosak,
- Irfan Dhanidina,
-
Jarret Engstrom,
Roles Funding acquisition, Methodology, Project administration
Affiliation Orion Biotechnology, Ottawa, Ontario, Canada
⨯ -
Bozena Korczak,
Roles Conceptualization, Methodology, Project administration, Writing – review & editing
Affiliation Orion Biotechnology Polska, Krakow, Poland
⨯ -
Ian McGowan,
Roles Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – review & editing
Affiliation Orion Biotechnology Polska, Krakow, Poland
⨯ -
Carissa Embury-Hyatt,
Roles Formal analysis, Investigation, Resources, Supervision, Writing – review & editing
Affiliation National Centre for Foreign Animal Diseases, Canadian Food Inspection Agency, Winnipeg, Manitoba, Canada
⨯ - [ ... ],
-
Darwyn Kobasa
Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing – review & editing
* E-mail: darwyn.kobasa@phac-aspc.gc.ca
Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada
⨯ - [ view all ]
- [ view less ]
Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection
- Bryce M. Warner,
- Robert Vendramelli,
- Amrit S. Boese,
- Jonathan Audet,
- Nikesh Tailor,
- Courtney Meilleur,
- Nathan Glowach,
- Marnie Willman,
- Thang Truong,
- Estella Moffat
- Published: February 5, 2025
- https://doi.org/10.1371/journal.pone.0316952